Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred.
ARHGEF28
FBXW10
HRAS
SLC47A1
XRCC1
familial non-medullary thyroid cancer (FNMTC)
papillary thyroid carcinoma (PTC)
protein–protein interactions (PPIs)
whole exome sequence (WES)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 May 2023
04 May 2023
Historique:
received:
30
03
2023
revised:
30
04
2023
accepted:
01
05
2023
medline:
15
5
2023
pubmed:
13
5
2023
entrez:
13
5
2023
Statut:
epublish
Résumé
Familial non-medullary thyroid cancer (FNMTC) is a well-differentiated thyroid cancer (DTC) of follicular cell origin in two or more first-degree relatives. Patients typically demonstrate an autosomal dominant inheritance pattern with incomplete penetrance. While known genes and chromosomal loci account for some FNMTC, the molecular basis for most FNMTC remains elusive. To identify the variation(s) causing FNMTC in an extended consanguineous family consisting of 16 papillary thyroid carcinoma (PTC) cases, we performed whole exome sequence (WES) analysis of six family patients. We demonstrated an association of
Identifiants
pubmed: 37175943
pii: ijms24098233
doi: 10.3390/ijms24098233
pmc: PMC10179265
pii:
doi:
Substances chimiques
XRCC1 protein, human
0
X-ray Repair Cross Complementing Protein 1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Israel Cancer Association
ID : 8756622
Références
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32333767
Endocrinol Metab Clin North Am. 2019 Mar;48(1):23-35
pubmed: 30717905
Biomolecules. 2019 Oct 13;9(10):
pubmed: 31614935
J Clin Endocrinol Metab. 2003 May;88(5):2318-26
pubmed: 12727991
Surgery. 2019 Jan;165(1):6-11
pubmed: 30415873
Proc Natl Acad Sci U S A. 2021 Aug 3;118(31):
pubmed: 34326253
Genes (Basel). 2019 Jun 26;10(7):
pubmed: 31247975
Endocr Pathol. 2020 Mar;31(1):14-20
pubmed: 32034658
J Clin Endocrinol Metab. 2013 Aug;98(8):E1401-9
pubmed: 23783103
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
J Clin Endocrinol Metab. 2015 Jan;100(1):E164-72
pubmed: 25303483
J Natl Cancer Inst. 2009 Feb 4;101(3):162-75
pubmed: 19176457
Cell Death Dis. 2016 Mar 31;7:e2163
pubmed: 27031960
Thyroid. 2011 Jan;21(1):43-8
pubmed: 20954815
Hum Mol Genet. 2015 Dec 20;24(25):7227-40
pubmed: 26464484
Genet Med. 2021 Aug;23(8):1381-1390
pubmed: 34012068
Thyroid. 2020 Jun;30(6):924-930
pubmed: 32041497
Mol Cell. 2006 Jun 23;22(6):731-740
pubmed: 16793543
PLoS Genet. 2013;9(12):e1004030
pubmed: 24367280
Sci Rep. 2015 Nov 04;5:16129
pubmed: 26530882
Thyroid. 2012 Apr;22(4):356-62
pubmed: 22280228
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4384-4394
pubmed: 30099483
Endocrinol Metab (Seoul). 2018 Jun;33(2):175-184
pubmed: 29947174
Int J Cancer. 2018 Oct 1;143(7):1706-1719
pubmed: 29672841
Endocr Relat Cancer. 2016 Dec;23(12):R577-R595
pubmed: 27807061
J Korean Med Sci. 2011 Aug;26(8):991-5
pubmed: 21860547
JAMA. 2011 Jan 5;305(1):68-77
pubmed: 21205968
Thyroid. 2013 Sep;23(9):1049-56
pubmed: 23734600
Front Endocrinol (Lausanne). 2022 Mar 04;13:845954
pubmed: 35311228
Endocr Pathol. 2022 Dec;33(4):437-445
pubmed: 36251117
Endocrine. 2015 May;49(1):204-14
pubmed: 25381600
Thyroid. 2021 Sep;31(9):1366-1375
pubmed: 33906393
N Engl J Med. 2016 Sep 15;375(11):1054-67
pubmed: 27626519
Biochem Biophys Res Commun. 2017 Jan 22;482(4):590-596
pubmed: 27864143
Semin Cancer Biol. 2022 Aug;83:253-260
pubmed: 33785446
J Clin Endocrinol Metab. 2005 Oct;90(10):5747-53
pubmed: 16030170
Endocrine. 2020 Jun;68(3):502-507
pubmed: 32162184
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):474-479
pubmed: 28049826
Structure. 2007 Dec;15(12):1618-29
pubmed: 18073111
Proc Natl Acad Sci U S A. 2022 Apr 26;119(17):e2119644119
pubmed: 35439056
Minerva Endocrinol (Torino). 2021 Mar;46(1):5-20
pubmed: 33045820
Sci Rep. 2015 Jul 02;5:10566
pubmed: 26135620
Am J Hum Genet. 2001 Aug;69(2):440-6
pubmed: 11438887
Int J Cancer. 2019 Mar 15;144(6):1321-1330
pubmed: 30132833
Oncogene. 2020 Mar;39(13):2658-2675
pubmed: 32005974
Hum Genome Var. 2016 Jun 30;3:16016
pubmed: 27408750
Thyroid. 2006 Feb;16(2):181-6
pubmed: 16613533
Cell Biosci. 2022 Feb 25;12(1):20
pubmed: 35216629
Lancet Diabetes Endocrinol. 2020 Jan;8(1):81-88
pubmed: 31591051
Int J Mol Sci. 2017 Jun 21;18(6):
pubmed: 28635633
Cancer Cytopathol. 2021 Feb;129(2):164-170
pubmed: 33030808
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Oncol. 2020 Jun 3;2020:2052396
pubmed: 32565797
Hered Cancer Clin Pract. 2022 Mar 7;20(1):9
pubmed: 35255942
Hum Mol Genet. 2004 May 15;13(10):1081-93
pubmed: 15044383
J Clin Endocrinol Metab. 2013 May;98(5):E973-80
pubmed: 23539728
Acta Neuropathol. 2012 Nov;124(5):733-47
pubmed: 22941224
Thyroid. 2009 Dec;19(12):1343-9
pubmed: 20001717
Thyroid. 2011 Apr;21(4):367-71
pubmed: 21190444
J Clin Endocrinol Metab. 2008 Nov;93(11):4426-30
pubmed: 18765515
Head Neck Pathol. 2022 Mar;16(1):190-199
pubmed: 35307774
Mol Cell Proteomics. 2018 Oct;17(10):2018-2033
pubmed: 30021884
J Clin Endocrinol Metab. 2000 May;85(5):1758-64
pubmed: 10843148
N Engl J Med. 2015 Jul 30;373(5):448-55
pubmed: 26222560
J Natl Cancer Inst. 2013 Nov 6;105(21):1617-27
pubmed: 24136889
Nat Commun. 2014 Aug 21;5:4706
pubmed: 25144556